Perindopril and indapamide is a combination medication used primarily to treat hypertension (high blood pressure) and to reduce the risk of cardiovascular events in patients with a history of coronary artery disease.
This combination is used for:
| Brand Name | Perindopril + Indapamide |
|---|---|
| Type | |
| Weight | |
| Generic | Perindopril + Indapamide |
| Manufacturer | |
| Available in | English বাংলা |
Perindopril is an angiotensin-converting enzyme (ACE) inhibitor that works by blocking the enzyme responsible for converting angiotensin I to angiotensin II, a potent vasoconstrictor. This leads to vasodilation and reduced blood pressure. Indapamide is a thiazide-like diuretic that helps lower blood pressure by promoting the excretion of sodium and water, reducing fluid overload and blood volume.
The antihypertensive effects of perindopril typically begin within 1-2 hours after ingestion, with peak effects seen in 4-6 hours. The blood pressure-lowering effects of indapamide can be observed within a few hours, with maximal effects achieved over several days.
Perindopril is well-absorbed from the gastrointestinal tract, with peak plasma concentrations occurring within 1 hour. Indapamide is also well-absorbed, with peak plasma levels reached within 1-2 hours.
Perindopril is primarily excreted in the urine, with approximately 60% of the dose eliminated as inactive metabolites and 20% as unchanged drug. Indapamide is excreted primarily through the urine, with a small portion eliminated in the feces.
The typical dosage is:
The combination medication is usually taken once daily, preferably in the morning. It should be taken with or without food, and the tablets should be swallowed whole with a glass of water.
Common side effects may include:
In case of overdose, symptoms may include severe hypotension, electrolyte imbalances, and dehydration. Treatment is supportive and symptomatic. Seek immediate medical attention in the event of an overdose.
- Monitor renal function and electrolytes regularly, especially in patients with pre-existing kidney issues. - Use cautiously in patients with a history of angioedema or severe hypersensitivity reactions. - Caution is advised in patients with a history of gout, diabetes, or liver disease.
This combination may interact with:
- Use with caution in patients with renal impairment or liver disease, as these conditions may alter drug metabolism and excretion. - Monitor blood glucose levels in diabetic patients, as thiazide-like diuretics can affect glucose tolerance.
- ACE inhibitors can interact with drugs that affect the renin-angiotensin system (e.g., ARBs, direct renin inhibitors). - Thiazide-like diuretics can interact with lithium, leading to increased lithium levels and toxicity.
Food does not significantly affect the absorption of this medication. However, a high-salt diet may reduce the efficacy of the antihypertensive effects.
This combination is generally not recommended during pregnancy, especially in the second and third trimesters, due to potential harm to the fetus. Consult a healthcare provider for alternatives if pregnancy is planned or suspected.
It is not known whether perindopril and indapamide are excreted in breast milk. Use during lactation should be approached with caution, and alternative treatments should be considered.
Acute overdose may lead to severe hypotension, electrolyte imbalances, and dehydration. Immediate medical treatment is necessary to address these issues and to provide supportive care.
This combination is contraindicated in:
Swallow the tablet whole, do not chew or crush. Take once daily in the morning with or without food. Adhere to the prescribed dosage and consult a healthcare provider for any adjustments or concerns.
Store at room temperature, away from moisture and heat. Keep out of reach of children.
The volume of distribution for perindopril is approximately 0.2-0.4 L/kg, reflecting its distribution primarily in the bloodstream and tissues. For indapamide, the volume of distribution is approximately 0.4-0.8 L/kg.
The half-life of perindopril is approximately 1-2 hours, while its active metabolite, perindoprilat, has a half-life of 8-9 hours. Indapamide has a half-life of about 14-24 hours.
Perindopril is cleared from the body primarily through the kidneys. Indapamide is also cleared primarily through the kidneys, with a small portion eliminated through the feces.
See in details version Perindopril + Indapamide also Perindopril + Indapamide in bangla
Prof. Dr. S A Khan
Urology (Kidney, Ureters, Bladder, Prostate) Specialist & Transplant Surgeon
Prof. Dr. S.M. Noman Khaled Chowdhury
Neurosurgery (Brain, Spine, Nerve Surgery) Specialist